ALPINE IMMUNE SCIENCES, INC. Accrued Liabilities, Current
ALPINE IMMUNE SCIENCES, INC. had Accrued Liabilities, Current of $16.89 million as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2024-05-09
- 2024-03-31: Accrued Liabilities, Current $16.89M.
- 2023-12-31: Accrued Liabilities, Current $21.19M.
- 2023-09-30: Accrued Liabilities, Current $17.79M.
- 2023-06-30: Accrued Liabilities, Current $13.68M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2024-03-31 | $16.89M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $21.19M 10-Q · filed 2024-05-09 | |
| 2023-09-30 | $17.79M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $13.68M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $12.03M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $14.00M 10-K · filed 2024-03-20 | |
| 2022-09-30 | $13.74M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $12.53M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $9.20M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $9.42M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $8.65M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $4.61M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $3.95M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $5.78M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $5.07M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $3.82M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $2.55M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $5.29M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $5.83M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $5.52M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $5.37M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $4.36M 10-K · filed 2020-03-30 | $4.28M 10-K · filed 2019-03-18 |
| 2018-09-30 | $4.31M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $585.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $586.00K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $382.00K 10-K · filed 2019-03-18 | |
| 2017-09-30 | $642.00K 10-Q · filed 2017-11-14 | |
| 2016-12-31 | $170.00K 10-K · filed 2018-03-28 |